Internal Medicine · Orange, CA
NPI
1093732992
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1010 W la Veta Ave, Ste 610
Orange, CA, 92868
Phone (707) 339-8802
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
1,543 services
Medicare patients, 2024
434
Average age 75
Drug cost, 2024
$1.4M
11,240 prescriptions
Company payments, 2025
$2,854
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald Daoud was code 99214 (office e&m - established), 340 times for 203 patients. In total Ronald Daoud billed 1,543 services in 29 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 340 | 203 | $90.83 | $31K |
| 99233 Hospital E&M - Subsequent | Facility | 330 | 108 | $92.73 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 166 | 118 | $12.59 | $2,089 |
| 99213 Office E&M - Established | Office | 130 | 101 | $66.09 | $8,592 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 110 | 110 | $133.34 | $15K |
| 99497 Care Management/Coordination | Office | 60 | 60 | $60.34 | $3,621 |
| 99309 SNF E&M | Facility | 57 | 19 | $82.96 | $4,728 |
| 99223 Hospital E&M - Initial | Facility | 54 | 48 | $133.08 | $7,187 |
| 83036 Blood Count | Office | 52 | 34 | $9.52 | $495 |
| G0008 Administration of influenza virus vaccine | Office | 35 | 34 | $9.80 | $343 |
| 93000 Electrocardiogram | Office | 32 | 31 | $10.53 | $337 |
| 90662 Vaccine Product | Office | 32 | 32 | $68.60 | $2,195 |
| 36415 Venipuncture Blood Collection | Office | 30 | 28 | $8.65 | $260 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 29 | 16 | $0.89 | $25.87 |
| 99204 Office E&M - New | Office | 28 | 28 | $106.55 | $2,983 |
By year: 2022 $176K for 2,020 services; 2023 $165K for 1,882 services; 2024 $115K for 1,543 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 52 | 34 | $9.52 | $495 |
| 36415 Venipuncture Blood Collection | 30 | 28 | $8.65 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald Daoud prescribed most often to Medicare patients was Levothyroxine Sodium, with 573 prescriptions and refills. In total Ronald Daoud wrote 11,240 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 573 | 1,418 | 162 | $7,040 |
| Atorvastatin Calcium Generic | 478 | 1,228 | 140 | $6,151 |
| Losartan Potassium Generic | 399 | 1,030 | 121 | $3,940 |
| Amlodipine Besylate Generic | 259 | 598 | 77 | $1,392 |
| Pantoprazole Sodium Generic | 254 | 568 | 82 | $3,352 |
| Metformin Hcl Generic | 237 | 636 | 77 | $1,548 |
| Rosuvastatin Calcium Generic | 231 | 587 | 74 | $4,013 |
| Zolpidem Tartrate Generic | 229 | 249 | 54 | $1,542 |
| Tamsulosin Hcl Generic | 222 | 502 | 68 | $3,458 |
| Gabapentin Generic | 193 | 319 | 52 | $3,466 |
| Tramadol Hcl Generic | 176 | 178 | 53 | $2,550 |
| Furosemide Generic | 174 | 324 | 48 | $891 |
| Eliquis Apixaban | 168 | 262 | 38 | $130K |
| Lisinopril Generic | 166 | 477 | 54 | $1,176 |
| Lorazepam Generic | 147 | 166 | 41 | $914 |
Brand drugs: 1,719 claims; generic drugs: 9,469 claims; opioid claims: 285.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald Daoud $2,854 ($2,854 in general payments such as food, travel and fees) from 33 companies. The largest payer was Janssen Pharmaceuticals, Inc with $556.
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc JNJ | 14 | $556 |
| Amgen Inc. AMGN | 27 | $436 |
| GlaxoSmithKline, LLC. GSK | 8 | $168 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $162 |
| Novo Nordisk Inc NVO | 8 | $148 |
| Aimmune Therapeutics, Inc. | 8 | $142 |
| Pfizer Inc. PFE | 7 | $140 |
| Exact Sciences Corporation EXAS | 4 | $121 |
| Abbvie Inc. ABBV | 4 | $104 |
| Lundbeck LLC | 5 | $88.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.